Ovarian cancer risk factors by histologic subtype: An analysis from the Ovarian Cancer Cohort Consortium

Journal of Clinical Oncology

Volumn 34, Issue 24, 2016, Pages 2888-2898

  Wentzensen, Nicolas ^a   Poole, Elizabeth M ^c,d   Trabert, Britton ^a   White, Emily ^e   Arslan, Alan A ^f   Patel, Alpa V ^h   Setiawan, V Wendy ⁱ   Visvanathan, Kala ^k   Weiderpass, Elisabete ^l,m,n,p   Adami, Hans Olov ^d,n   Black, Amanda ^a   Bernstein, Leslie ^j   Brinton, Louise A ^a   Buring, Julie ^c,d   Butler, Lesley M ^q   Chamosa, Saioa ^r   Clendenen, Tess V ^f   Dossus, Laure ^s   Fortner, Renee ^u   Gapstur, Susan M ^h   Gaudet, Mia M ^h   Gram, Inger T ^l   Hartge, Patricia ^a   Hoffman Bolton, Judith ^k   Idahl, Annika ^o   Jones, Michael ^v   Kaaks, Rudolf ^u   Kirsh, Victoria ^y   Koh, Woon Puay ^z   Lacey, James V ^j   Lee, I Min ^c,d   Lundin, Eva ^o   Merritt, Melissa A ^w   Onland Moret, N Charlotte ^aa   Peters, Ulrike ^e   Poynter, Jenny N ^ac   Rinaldi, Sabina ^t   Robien, Kim ^ad   Rohan, Thomas ^g   Sandler, Dale P ^b   Schairer, Catherine ^a   Schouten, Leo J ^ab   Sjöholm, Louise K ⁿ   Sieri, Sabina ^ae   Swerdlow, Anthony ^v   Tjonneland, Anna ^af   Travis, Ruth ^x   Trichopoulou, Antonia ^ag   Van Den Brandt, Piet A ^ab   Wilkens, Lynne ^ah   Wolk, Alicja ⁿ   Yang, Hannah P ^a   Zeleniuch Jacquotte, Anne ^f   Tworoger, Shelley S ^c,d   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD UNIVERSITY   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h AMERICAN CANCER SOCIETY   (United States)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^j CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^k JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^l UNIVERSITY OF TROMSØ   (Norway)

^m CANCER REGISTRY OF NORWAY   (Norway)

ⁿ KAROLINSKA INSTITUTE   (Sweden)

^o UMEÅ UNIVERSITY   (Sweden)

^p FOLKHÄLSAN RESEARCH CENTER   (Finland)

^q UNIVERSITY OF PITTSBURGH   (United States)

^r BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^s Epidemiology and Biostatistics Sorbonne Paris Cité Research Center   (France)

^t INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^u GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^v INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^w IMPERIAL COLLEGE LONDON   (United Kingdom)

^x UNIVERSITY OF OXFORD   (United Kingdom)

^y UNIVERSITY OF TORONTO   (Canada)

^z DUKE UNIVERSITY   (United States)

^aa UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ab MAASTRICHT UNIVERSITY   (Netherlands)

^ac UNIVERSITY OF MINNESOTA   (United States)

^ad GEORGE WASHINGTON UNIVERSITY   (United States)

^ae REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^af DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^ag HELLENIC HEALTH FOUNDATION   (Greece)

^ah UNIVERSITY OF HAWAII   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RISK; CLEAR CELL CARCINOMA; COHORT ANALYSIS; COLLOID CARCINOMA; ENDOMETRIOID CARCINOMA; ENDOMETRIOSIS; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MENOPAUSE; MIDDLE AGED; MULTICENTER STUDY; OVARY CARCINOMA; PARITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING; UTERINE TUBE LIGATION; ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; ASIA; CARCINOMA, ENDOMETRIOID; CYSTADENOCARCINOMA, SEROUS; EUROPE; NEOPLASMS, GLANDULAR AND EPITHELIAL; NORTH AMERICA; OVARIAN NEOPLASMS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; ADULT; ASIA; CARCINOMA, ENDOMETRIOID; CYSTADENOCARCINOMA, SEROUS; EUROPE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; NORTH AMERICA; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84980507559     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.66.8178     Document Type: Article

References (38)

1. Ferlay J, Soerjomataram I, Dikshit R, et al: Cancer incidence and mortality worldwide: Sources, methods andmajor patterns in GLOBOCAN 2012. Int J Cancer 136:E359-E386, 2015
2. Buys SS, Partridge E, Black A, et al: Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA 305:2295-2303, 2011
3. Jacobs IJ, Menon U, Ryan A, et al: Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A randomised controlled trial. Lancet 387:945-956, 2016
4. Fathalla MF: Incessant ovulation-a factor in ovarian neoplasia. Lancet 2:163, 1971
5. Ness RB, Cottreau C: Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 91:1459-1467, 1999
6. Rice MS, Hankinson SE, Tworoger SS: Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies. Fertil Steril 102:192-198, 2014
7. Trabert B, Ness RB, Lo-Ciganic WH, et al: Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: A pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst 106:djt431, 2014
8. Jarboe EA, Folkins AK, Drapkin R, et al: Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology 55:619, 2009
9. Kurman RJ, Shih Ie M: Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Hum Pathol 42:918-931, 2011
10. Steffensen KD, Waldstrøm M, Grove A, et al: Improved classification of epithelial ovarian cancer: Results of 3 Danish cohorts. Int J Gynecol Cancer 21:1592-1600, 2011
11. Collaborative Group on Epidemiological Studies of Ovarian Cancer: Ovarian cancer and body size: Individual participant meta-analysis including 25, 157 women with ovarian cancer from 47 epidemiological studies. PLoS Med 9:e1001200, 2012
12. Beral V, Doll R, Hermon C, et al: Ovarian cancer and oral contraceptives: Collaborative reanalysis of data from 45 epidemiological studies including 23, 257 women with ovarian cancer and 87, 303 controls. Lancet 371:303-314, 2008
13. Beral V, Gaitskell K, Hermon C, et al: Ovarian cancer and smoking: Individual participant metaanalysis including 28, 114 women with ovarian cancer from 51 epidemiological studies. Lancet Oncol 13:946-956, 2012
14. Beral V, Gaitskell K, Hermon C, et al: Menopausal hormone use and ovarian cancer risk: Individual participant meta-analysis of 52 epidemiological studies. Lancet 385:1835-1842, 2015
15. Fortner RT, Ose J, Merritt MA, et al: Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort. Int J Cancer 137:1196-1208, 2015
16. Gates MA, Rosner BA, Hecht JL, et al: Risk factors for epithelial ovarian cancer by histologic subtype. Am J Epidemiol 171:45-53, 2010
17. Yang HP, Trabert B, Murphy MA, et al: Ovarian cancer risk factors by histologic subtypes in the NIHAARP Diet and Health Study. Int J Cancer 131:938-948, 2012
18. Lunn M, McNeil D: Applying Cox regression to competing risks. Biometrics 51:524-532, 1995
19. Olsen CM, Nagle CM, Whiteman DC, et al: Obesity and risk of ovarian cancer subtypes: Evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer 20:251-262, 2013
20. Pearce CL, Templeman C, Rossing MA, et al: Association between endometriosis and risk of histological subtypes of ovarian cancer: A pooled analysis of case-control studies. Lancet Oncol 13:385-394, 2012
21. Schouten LJ, Rivera C, Hunter DJ, et al: Height, body mass index, and ovarian cancer: A pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 17:902-912, 2008
22. Adami HO, Hsieh CC, Lambe M, et al: Parity, age at first childbirth, and risk of ovarian cancer. Lancet 344:1250-1254, 1994
23. Setiawan VW, Yang HP, Pike MC, et al: Type I and II endometrial cancers: Have they different risk factors. J Clin Oncol 31:2607-2618, 2013
24. Newcomb PA, Storer BE, Marcus PM: Cigarette smoking in relation to risk of large bowel cancer in women. Cancer Res 55:4906-4909, 1995
25. Yang XR, Chang-Claude J, Goode EL, et al: Associations of breast cancer risk factors with tumor subtypes: A pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 103:250-263, 2011
26. Cancer Genome Atlas Network: Comprehensive molecular portraits of human breast tumours. Nature 490:61-70, 2012
27. Köbel M, Bak J, Bertelsen BI, et al: Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry. Histopathology 64:1004-1013, 2014
28. Matsuno RK, Sherman ME, Visvanathan K, et al: Agreement for tumor grade of ovarian carcinoma: Analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository. Cancer Causes Control 24:749-757, 2013
29. Vang R, Shih Ie M, Kurman RJ: Ovarian lowgrade and high-grade serous carcinoma: Pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol 16:267-282, 2009
30. Kotsopoulos J, Terry KL, Poole EM, et al: Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin. Int J Cancer 133:730-739, 2013
31. Poole EM, Merritt MA, Jordan SJ, et al: Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness. Cancer Epidemiol Biomarkers Prev 22:429-437, 2013
32. Cancer Genome Atlas Research Network: Integrated genomic analyses of ovarian carcinoma. Nature 474:609-615, 2011
33. Tothill RW, Tinker AV, George J, et al: Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res 14:5198-5208, 2008
34. Schildkraut JM, Iversen ES, Akushevich L, et al: Molecular signatures of epithelial ovarian cancer: Analysis of associations with tumor characteristics and epidemiologic risk factors. Cancer Epidemiol Biomarkers Prev 22:1709-1721, 2013
35. Levine DA, Karlan BY, Strauss JF III: Evolving approaches in research and care for ovarian cancers: A report from the National Academies of Sciences, Engineering, and Medicine. JAMA, 315:1943-1944, 2016
36. Trabert B, Pinto L, Hartge P, et al: Prediagnostic serum levels of inflammation markers and risk of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) screening trial. Gynecol Oncol 135:297-304, 2014
37. Trabert B, Brinton LA, Anderson GL, et al: Circulating estrogens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study. Cancer Epidemiol Biomarkers Prev, 10.1158/1055-9965. EPI-15-1272-T [epub ahead of print on February 5, 2016]
38. Pfeiffer RM, Park Y, Kreimer AR, et al: Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: Derivation and validation from populationbased cohort studies. PLoS Med 10:e1001492, 2013